In this most recent emerging technology note, our analysts delve into the femtech vertical, providing a segmentation of the industry along with an analysis of VC investment, market size, barriers to raising capital, and potential growth areas in the space. The industry has generated just over $376 million in VC across 57 deals so far in 2020, putting the year on pace to match levels from 2019. Femtech's large market opportunity, conducive regulatory environment, and health IT advancements, among other factors, provide a positive outlook for the segment. In addition, this note examines some challenges investors in the femtech space have experienced when raising capital, including the lower percentage of VC that goes to companies with at least one female founder compared to companies with only male founders. However, many growth areas exist as a personalized, female-oriented approach to general health & disease management takes hold in the industry and startups that target health concerns such as menopause and endometriosis gain investor attention.